AI promises to transform biotech, but real-world results are more incremental. A practical perspective on AI in drug discovery, genomics, diagnostics, and lab automation.

Discover kbDNA’s rapid workflow for repurifying rituximab biosimilars to high-purity standards—featuring SEC overlays, gel schematics, and SOPs.

Unfiltered truths, hidden risks, and real data behind life sciences R&D in North America. Discover the facts nobody else is sharing—read the full report now

This article explores the complexities of biosimilars, including their development process, regulatory challenges, economic impact, and future prospects. It highlights the potential of biosimilars to reduce healthcare costs and increase patient access to biologic therapies, providing valuable insights for biopharmaceutical and academic researchers.

Explore key insights and major trends from a decade of JPM Biotech conferences. Download our exclusive 2025 prospectus for the latest in biotech deals and innovations.

The FLAG tag (DYKDDDDK) is an epitope tag widely utilized in biopharmaceutical research for protein purification, detection, and functional analysis. This article provides an in-depth examination of FLAG tag technology, its advantages, limitations, and diverse applications. Additionally, it explores current research trends and future directions in FLAG tag technology, making it a pivotal tool in advancing drug discovery and development.

Discover the latest advancements in peptide synthesis at kbDNA. Learn about innovative techniques, optimized reagents, and cutting-edge technologies that enhance research efficiency and outcomes.

kbDNA Leads the Charge In Compliance and Security

Discover essential tips and protocols for handling and preparing synthesized peptide sequences. Learn how to tailor your approach to the unique characteristics of your peptides to ensure successful outcomes in your research